This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.
QUICK READ: Patients are returning to their doctor’s office, and it’s not uncommon for appointments, or routine visits, to be scheduled weeks or months in advance. When I sent an email to my doctor’s office, I was shocked when she said the earliest appointment she had for physicals was in September.
SUMMARY: The media headlines promise weight loss for diabetes patients, but Norvo’s new drug is in the same class as other drugs and carries many warnings. Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost?
The passage of the Inflation Control bill is an excellent first step in limiting high drug costs, but our healthcare system is still built for profit at the expense of patients. First, the health insurance companies are making a lot of money while burying doctors in paperwork and limiting treatment options. The result:? The result:?
SUMMARY: Physicians are tired and overwhelmed with medical information on new drugs. A client launched an Oncology drug based on extensive research with physicians, but the results were not that good during a post-launch evaluation. 4our: There are too many messages associated with new drugs. It’s a huge challenge.
The days of someone seeing an ad for a prescription drug and rushing to ask their doctor about it have replaced the quest for more information, usually online. CPG brands have finally admitted that consumers are changing how they purchase products and brands. What can we learn from this?
New survey data from Press Ganey suggests that pharma may be able to get an edge by integrating physician directories into brand websites. By embedding a provider directory in the company’s website or brand websites. say finding the right doctor is a challenge. That number is up 17% from 2019. A newfound trust in pharma.
Consumers would ask their doctor about an advertised prescription drug in a perfect world. Ask current patients what drove them to get an Rx for a branded product (MS drug). Most patients said they had done more research online or talked to other patients about their experience before asking their doctor about the brand.
The pharmaceutical industry often relies on enzymes to perform a process known as biocatalysis, which facilitates the cost-effective and sustainable production of small molecule drugs at scale. The post Enabling the next wave of innovative drug therapies with speciality enzymes appeared first on Pharmaceutical Technology.
DTC marketers would like to think that patients ask for the advertised drug when visiting their doctor, but that’s largely untrue. Call’s to action, such as coupons, are believed to a great tactic to generate new Rx’s but in my analysis less than 10% of coupons, for new drugs, have been used.
KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. Yes, the telehealth numbers are high, but they will level off when people feel safe to go back to their doctor. 2wo: To ignore telehealth is a huge error.
SUMMARY: Online health seeker numbers are still very high, indicating that people are doing their research first before asking for a prescription drug. Online ads for prescription drugs are unique. Nobody will see an online ad for a prescription drug and ask their doctor about it without doing some research first.
I’ve seen a real change in the way people are making treatment decisions when it comes to prescription drugs. You need people who can understand what your brand is trying to do and develop an online strategy that checks all the boxes. Today a great MSL team can mean the difference between a successful brand launch and a flop.
SUMMARY: Several online providers promise that they can reach physicians with your message, but I would argue that numbers are only important if they can be measured against key brand objectives. Finally, after the storm of the pandemic, many doctors re suddenly overwhelmed with patients.
First, pharma marketers must understand what social media can and can’t do and that its use does not apply to all health conditions and brands. The second issue is to ensure that someone monitors social media analytics to see who engages with the brand. According to the CDC, prescription drug use increases with age, from 18.0%
6ix: Online health seekers trust pharma products, but they are “very concerned” about rising drug costs as their health insurance rates climb. Their doctor was a distant second. 9ine: Hard to pronounce brandeddrug names often is a barrier to getting more information online. Their doctor was a distant second.
QUICK READ: Reaching physicians with key brand messages isn’t hard, but the online landscape has become crowded with many players. By far, Medscape is still number one in physician reach , and medical journal advertising has been proven to result in more branded Rx’s. But there are also warnings. 2017 study.
According to a study in the Journal for American Board of Family Medicine “respondents (76%) said they were likely to ask a health care provider about advertised drugs; 26% said they had already done so. 2wo: Consumers are not blindly going to ask for/about an advertised drug. Today people go online to learn more about the drug.
3hree: Online data indicates that people want more in fo rmation from advertised brands – Data for the top brands via Google trends shows that people want more information about drug side effects and prices in simple, easy-to-understand language. The post Pharma spent $3.9B on <b>TV</b> ads in 2021.
TV still gets the biggest share of DTC budgets, but they don’t drive brand objectives. There are too many inexperienced DTC brand directors (not that I mind as it means more work for me) who are being led by people who are only interested in pleasing clients and getting paid. There are several things going on here.
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. They’re surprised that physicians don’t always give patients the drug they ask for, and they are amazed that many, who are considering the drug, are turned away by what they read online. Running T.V.
All this means is that DTC and HCP marketers will have to do a lot better job connecting their spending to quantitative brand metrics. Initial research indicates that drug reps are becoming less effective, and they are the number one target to reduce costs. They should be measuring bounce rate, pages viewed, and time on site.
A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand. The research showed that patients wanted to understand how the drug works and the potential side effects.
A new feature—a sensor that monitors changes in the heart rate for irregularities that can lead to strokes and heart failure—has just been approved by America’s Food and Drug Administration (FDA). The new initiative, Care Studio, aims at doctors rather than patients. Then there is the cost of generic drugs.
Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its antiepileptic medications, with greater capabilities to expand across additional brands. million patients in the US who live with the neurological condition.
QUICK READ : Prescribers are reviewing some of their favorite prescribed drugs and are open to learning about new drugs in terms of efficacy and patient outcomes but you had better be ready to talk about patients beyond the science. Some may think it’s a bad time to be launching a drug but actually the reverse may be true.
QUICK READ: According to Setup 30% of Brand marketers say they’re likely/somewhat likely to switch Agencies in the next 6 months. Setup also found that one third of brand marketers want their agencies to better understand their business + seek greater transparency and communication between Agency and Brand.
First, there is the misinformation on the web, and second, there is a fear of drug side effects that are applied because of the drugs used to treat and prevent—the pandemic. If you plan to launch a new drug with the model of heavy-up TV and a website with some programmatic ads, you’re going to fail.
DTC marketers will do a lot of research on brand messaging, but what’s really important is what action your target audience will take due to being exposed to your message. Under no circumstances should ANY DTC marketer believe that a patient is going to ask their doctor about/for your product as a result of seeing your DTC TV ad.
However, with pharma brands, online is essential to a successful marketing strategy. Over 95% of people, when hearing about new treatment options, will go online BEFORE asking their doctor for/about the product. For this reason, digital marketing is an essential part of any pharma brand. The answer is twofold.
In the CPG sector there is a new emphasis on omnichannel marketing, but, the FDA is still stuck in the past and won’t allow pharma to get more personal with prescription drug marketing. Your digital marketing people should be providing you with a decision treemap that shows the noise between your brand and patients asking for an Rx.
It was the weekend: his doctor wasn’t available, an emergency department provider told him he might have anal cancer, and an urgent care provider sent him home with Tylenol and no diagnosis. Andy couldn’t sleep more than a couple fitful hours a night because it felt like a hot fork was stabbing him in the butt.
FINDING : Doctors across the globe report a significant increase in the consumption of online medical content compared to pre-pandemic levels. Drug companies need to develop a model in which there is continuous improvement in online interactions. Medscape Detailed Findings.
SUMMARY: Both emergency room visits and doctors’ visits are down by about half because people are putting off treatment for medical emergencies due to fears of contracting COVID-19. How is pharma going to get patients back into to ask their doctor about branded medications? This is especially true for undiagnosed patients.
Today virtually nobody will ask their doctor for/about a new prescription drug product without doing online research. Make your brand the health condition’s voice by providing good unbiased content written by your thought leaders. The disconnect happens in the reliance on TV to drive new Rx’s.
Lilly’s new diabetes drug is being talked about all over social media because of its weight loss properties, but what’s not mentioned is that it requires a diet modification and has side effects that can cause more severe health issues. Why don’t doctors have the “the talk”?
With its ability to combine visuals, messaging, and precise targeting, display advertising can transform brand visibility and drive impressive ROI. Display advertising uses visually engaging ads, such as banners and videos, to promote a product or brand online. But how can pharma marketers harness its full potential?
Drug Discovery and Manufacturing: It helps in the initial screening of drug compounds to the predicted success rate based on biological factors. Precision medicine or next-generation sequencing helps in the faster discovery of drugs and tailored medication for individual patients. . Measuring RNA, DNA quickly.
This month, HRA Pharma announced it had submitted the first-ever application to the Food and Drug Administration to turn its birth control pill, Opill , from prescription to over-the-counter (OTC) status. Read the rest…
Ask a DTC marketer this question, and you’ll probably hear that their product website is there to answer questions about their drug or to drive brand objectives. If you believe that TV ads are really driving your brand objectives, you probably believe the earth isn’t round. 3hree: What about paid media online?
Pfizer is recalling three more lots of its smoking cessation drug Chantix (varenicline) after having issued a voluntary recall of the drug earlier this month due to carcinogen concerns, bringing the total number of affected lots to 12. As a result, there are currently shortages of the drug in the US.
The excitement about these technologies partially stems from their potential to address health care system challenges that have slightly improved with traditional health care processes, payment models, regulations, guidelines, and innovations such as drugs and devices.
Advertising is meant to “sell” your product, but the pharma industry is unique because people don’t just see an ad for a prescription drug and run to their doctor. Your brand can become the “go-to” site for credible medical information by having more content centered around patient needs.
Porter points out that R&D seems to have been replaced with mergers and acquisitions, but she misses the big picture by focusing solely on drug costs. So where to start… Congresswoman Porter may want to look at the percentage of generic drugs available virus branded (89%). In pharma R&D returns have declined to 1.8
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content